외용약 전달 시장

The global topical drug delivery market was valued at $222.9 billion in 2025 and is estimated to increase from $239 billion in 2026 to reach $362.3 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2031.

Report Scope

The report provides an overview of the global topical drug delivery market and analyzes market trends. It includes global revenue ($ Billion) for the base year of 2025 and estimated revenue for the forecast period of 2026 through 2031. The market is segmented by product type, drug class, end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with a focus on the major countries in each region.

The report focuses on the key driving trends and challenges shaping the market and vendor landscape.

The report concludes with an analysis of the competitive landscape, which provides market shares for key participants in the global topical drug delivery market. It also includes a dedicated section of company profiles that covers details of leading companies in the market.

Report Includes

• 63 data tables and 55 additional tables
• An overview and analysis of the global topical drug delivery market
• Market size estimates for 2025 (base year) and forecasts for the period 2026 through 2031
• Estimates of the current market size and growth prospects, with a market share analysis by product type, drug class, route of administration, end user, and region
• Facts and figures related to market dynamics, including key drivers, restraints, challenges, and opportunities
• Review of macroeconomic factors, U.S. tariff impacts, and insights derived from Porter's Five Forces analysis
• Overview of the regulatory landscape affecting topical drug delivery products across major regions
• Discussion of emerging technologies and developments, including advanced formulations, transdermal systems, and novel delivery approaches
• Patent review and analysis of recent developments related to topical drug delivery technologies
• Analysis of the competitive landscape, including market share rankings, strategic initiatives, and venture funding activity
• Company profiles of major players within the industry, including Galderma, Kenvue, Bayer AG, Haleon, and AbbVie Inc.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Overview
• Current Market Scenario
• Segmental Analysis
• Regional Analysis
• Emerging Technologies
• Conclusion

Chapter 2 Market Overview

• Overview
• Macroeconomic Factors
• Porter's Five Forces Analysis

Chapter 3 Market Dynamics

• Market Dynamics
• Market Drivers
• Increasing Prevalence of Skin Diseases
• Growing Patient Preference for Painless Treatments
• Chronic Disease Management and Aging Population
• Growth in Pharmaceutical R&D
• Market Restraints
• Limited Skin Permeability
• Skin Irritation and Allergic Reactions
• High Development Costs for Advanced Formulations
• Regulatory and Approval Challenges
• Market Opportunities
• Emerging Economies
• Technological Advances in Drug Delivery

Chapter 4 Regulatory Landscape

• Overview
• U.S.
• Europe
• Asia-Pacific

Chapter 5 Emerging Technologiesand Developments

• Key Takeaways
• Microneedle-Based Drug Delivery
• Nanoparticle-Based Drug Delivery Systems
• Smart Transdermal Patches and Wearable Systems
• 3D-Printed Drug Delivery Systems
• Stimuli-Responsive and Controlled-Release Systems
• Artificial Intelligence (AI) in Topical Drug Delivery
• Patent Analysis
• Key Findings

Chapter 6 Market Segmentation Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Key Takeaways
• Semi-Solid Formulations
• Liquid Formulations
• Transdermal Patches
• Solid Formulations
• Market Analysis by Drug Class
• Key Takeaways
• Corticosteroids
• Anti-inflammatories
• Anti-infectives
• Analgesics
• Others
• Market Analysis by End User
• Key Takeaways
• Home Care Settings
• Hospitals and Clinics
• Burn Care Centers
• Others
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Competitive Intelligence

• Key Takeaways
• Competitive Analysis
• Strategic Initiatives
• Acquisitions
• Partnership and Collaborations
• Product Launches/Approvals

Chapter 8 Appendix

• Research Methodology
• Sources
• Abbreviations
• Company Profiles
• ABBVIE INC.
• ALMIRALL
• BAUSCH HEALTH COMPANIES INC.
• BAYER AG
• GALDERMA
• GLENMARK PHARMACEUTICALS LTD.
• GSK PLC
• HALEON PLC
• HISAMITSU PHARMACEUTICAL CO. INC.
• JOHNSON & JOHNSON SERVICES INC.
• KENVUE
• LEO PHARMA A/S
• SANOFI
• SOLVENTUM
• TEVA PHARMACEUTICAL INDUSTRIES LTD.
• Few Emerging Startups/Market Disruptors